左胰腺切除术后胰瘘预测模型的国际多中心验证及DISPAIR-FRS联合模型的开发与验证
本研究基于9个高容量胰腺手术中心2284例左胰腺切除患者的回顾性队列,验证并比较DISPAIR与D-FRS两种术前胰瘘预测模型,两者AUC均为0.62,表现欠佳。研究者整合两模型中最稳定的预测因子并纳入年龄、性别、横断部位、胰腺厚度及主胰管直径等变量,构建DISPAIR-FRS新模型,内部-外部验证AUC为0.72,校准斜率0.93、截距-0.02,性能优于原模型。
要点
- DISPAIR与D-FRS原始模型在2284例左胰腺切除队列中AUC均为0.62,区分度欠佳。
- 新模型DISPAIR-FRS内部-外部验证AUC为0.72,校准斜率0.93、截距-0.02。
- DISPAIR-FRS可在线访问(www.tinyurl.com/the-dispair-frs),辅助术前风险评估与决策。
核心结论
- DISPAIR与D-FRS两种左胰腺切除术后胰瘘预测模型在多中心验证中表现欠佳,AUC均为0.62。
- 整合两模型稳定预测因子及额外人口学与解剖变量构建的DISPAIR-FRS模型性能更优,内部-外部验证AUC为0.72。
研究设计与样本
- 回顾性队列研究,纳入9个高容量胰腺手术中心(欧洲8个、北美1个)2010年以来接受开放或微创左胰腺切除、年龄>18岁的患者。
- 共纳入2284例患者,其中497例(21.8%)发生术后胰腺瘘(POPF)。
- 采用ROC曲线评估区分度、校准图评估校准度,以逻辑回归开发更新模型并进行内部-外部验证。
主要发现
- 2284例患者中497例(21.8%)发生POPF。
- DISPAIR模型AUC为0.62,D-FRS模型AUC为0.62,在合并验证队列及逐中心分析中均表现欠佳。
- DISPAIR-FRS模型内部-外部验证AUC为0.72,校准斜率0.93,截距-0.02。
关键数值与推荐
- DISPAIR与D-FRS的AUC均为0.62。
- DISPAIR-FRS内部-外部验证AUC为0.72,校准斜率0.93,截距-0.02。
- POPF发生率为21.8%(497/2284)。
临床怎么用
- DISPAIR-FRS可用于左胰腺切除术前评估POPF风险,辅助手术决策与患者沟通。
- 模型在线工具(www.tinyurl.com/the-dispair-frs)可供外科医生、研究者及患者使用。
局限性
- 原文未报告局限性相关内容。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Every fifth patient undergoing left pancreatectomy develops a postoperative pancreatic fistula (POPF). Accurate POPF risk prediction could help. Two independent preoperative prediction models have been developed and externally validated: DISPAIR and D-FRS. The aim of this study was to validate, compare, and possibly update the models. METHODS: Patients from nine high-volume pancreatic surgery centres (8 in Europe and 1 in North America) were included in this retrospective cohort study. Inclusion criteria were age over 18 years and open or minimally invasive left pancreatectomy since 2010. Model performance was assessed with discrimination (receiver operating characteristic (ROC) curves) and calibration (calibration plots). The updated model was developed with logistic regression and internally-externally validated. RESULTS: Of 2284 patients included, 497 (21.8%) developed POPF. Both DISPAIR (area under the ROC curve (AUC) 0.62) and D-FRS (AUC 0.62) performed suboptimally, both in the pooled validation cohort combining every centre's data and centre-wise. An updated model, named DISPAIR-FRS, was constructed by combining the most stable predictors from the existing models and incorporating other readily available patient demographics, such as age, sex, transection site, pancreatic thickness at the transection site, and main pancreatic duct diameter at the transection site. Internal-external validation demonstrated an AUC of 0.72, a calibration slope of 0.93, and an intercept of -0.02 for the updated model. CONCLUSION: The combined updated model of DISPAIR and D-FRS named DISPAIR-FRS demonstrated better performance and can be accessed at www.tinyurl.com/the-dispair-frs. Left pancreatectomy is a type of pancreatic surgery where only the left part of the pancreas is removed. Pancreatic fistula is a serious complication that refers to leakage of digestive fluids produced by the pancreas. Re-intervention is often needed. It can prolong hospital stay and, in some patients, leakage finally leads to death. Knowing who will develop pancreatic fistula is difficult. Two risk scores that try to estimate a patient’s risk of pancreatic fistula have been developed. The authors tested how well they work. The authors collected data from over 2000 patients who had undergone left pancreatectomy. Data were collected from seven different countries. Both of the risk scores performed poorly using these data. The authors combined parts from the risk scores that had potential and used statistical methods to build a new risk score. This new risk score—called DISPAIR-FRS—performed much better than the previous ones. It could be used in the future to help surgeons, scientists, and patients with making decisions and planning studies.
引用
- Bonsdorff A, Kjeseth T, Kirkegård J, et al. International multicentre validation of the left pancreatectomy pancreatic fistula prediction models and development and validation of the combined DISPAIR-FRS prediction model. Br J Surg. 2025. PMID: 40114539. doi:10.1093/bjs/znae313
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。